It is reported that GNMT, the most abundant methyltransferase in the liver [55], has tumor suppressor function [56] and is associated with nonalcoholic fatty liver disease (NAFLD) which accompanies hepatic methionine deficiency and homocysteine elevation [57–59] (Fig 3). This evidence concerns the gene GNMT and metabolic dysfunction-associated steatotic liver disease.